The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A

• Status: Unknown status
• Trial end date: 2010-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Influenza continues to inflict an important burden on health-care systems. The 2009 H1N1 influenza virus first appeared in Mexico and the United States in March and April 2009 and has swept the globe with unprecedented speed.

The aim of this study is to evaluate effect of supplement vitamin on the clinical course of patients with acute respiratory illness suspected novel H1N1 infection.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Antipyretics; Antiviral Agents; Retinol palmitate; Vitamin A; Vitamins

Criteria

Inclusion Criteria:

• Age > 20 years

• Acute respiratory illness suspected H1N1 infection

• Acute febrile respiratory illness(BT > 37.8) and throat pain or cough or nasal congestion

Exclusion Criteria:

• Pregnancy

• Hypersensitivity to vitamin A

• History of liver disease or renal disease

• Urinary stone disease